WuXi AppTec Co., Ltd. hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü altı ayda bir ödenmektedir ve son temettü hariç tarihi Sep 9, 2025 tarihindedir.
Dividend Yield
Yıllık Dividende
Özsermaye Tarihi
0.00%
$0.10
Sep 9, 2025
Ödeme Sıklığı
Ödeme Oranı
Altı ayda bir
0.00%
Dividend History
Özsermaye Tarihi
Nakit Tutarı
Kayıt Tarihi
Ödeme Tarihi
Sep 9, 2025
$0.0494
Sep 9, 2025
Oct 10, 2025
May 19, 2025
$0.136
May 19, 2025
Jun 20, 2025
May 19, 2025
$0.0485
May 19, 2025
Jun 20, 2025
May 9, 2025
$0.1345
May 9, 2025
Jul 15, 2025
May 9, 2025
$0.048
May 9, 2025
Jul 15, 2025
Jun 18, 2024
$0.1392
Jun 18, 2024
Jul 19, 2024
Dividend Grafikleri
WUXAY Kâr Payları
WUXAY Dividend Growth (Yıllık Üstünlük)
Follow-Up Questions
WuXi AppTec Co., Ltd.'in şu anki temettü ödemesi ve yıllık temettüsü nedir?
WuXi AppTec Co., Ltd.'in temettü ödeme oranı nedir?
WUXAY'ün temettü dağıtım tarihi nedir?
WuXi AppTec Co., Ltd. ne sıklıkla temettü öder?
Önemli İstatistikler
Önceki Kapanış
$14.16
Açılış fiyatı
$14.47
Günün Aralığı
$14.47 - $15.31
52 haftalık aralık
$5.73 - $15.95
İşlem hacmi
104
Ort.Hacim
1.7K
EPS (TTM)
0.75
Dividend yield
--
Piyasa Değeri
$37.0B
Wuxi Apptec Co Ltd. nedir?
WuXi AppTec Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Shanghai, Shanghai and currently employs 39,414 full-time employees. The company went IPO on 2018-05-08. WuXi AppTec Co Ltd is a China-based company principally engaged in the business of new drug research and development and manufacturing services. The firm conducts its business through six segments. The WuXi Chemistry Segment is primarily engaged in providing new drug research, development and manufacturing services. The WuXi Testing Segment is primarily engaged in providing pharmaceuticals, medical devices, and in vitro diagnostic reagents services. The WuXi Biology Segment is primarily engaged in providing drug discovery and research services. The WuXi ATU Segment is primarily engaged in providing customers with integrated medical product process development, manufacturing and testing services. The WuXi DDSU Segment is primarily engaged in providing customers with integrated new drug research and development services. The Other Segment is primarily engaged in administrative services, sales of raw materials and sales of waste materials.